These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29960007)

  • 1. Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Tansarli GS; Papaparaskevas J; Balaska M; Samarkos M; Pantazatou A; Markogiannakis A; Mantzourani M; Polonyfi K; Daikos GL
    Int J Antimicrob Agents; 2018 Sep; 52(3):397-403. PubMed ID: 29960007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
    Monaco M; Giani T; Raffone M; Arena F; Garcia-Fernandez A; Pollini S; ; Grundmann H; Pantosti A; Rossolini GM
    Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
    Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
    Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producing Klebsiella pneumoniae.
    Maraki S; Papadakis IS
    J Chemother; 2015; 27(6):348-52. PubMed ID: 25248023
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
    Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
    Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
    Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae.
    Matheeussen V; Xavier BB; Mermans I; De Weerdt A; Lammens C; Goossens H; Jansens H; Malhotra-Kumar S
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):407-409. PubMed ID: 30890297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
    Jayol A; Poirel L; Dortet L; Nordmann P
    Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Level Resistance to Colistin Mediated by Various Mutations in the
    Jayol A; Nordmann P; Brink A; Villegas MV; Dubois V; Poirel L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Fitness Costs of
    Giordano C; Klak A; Barnini S; Chlebowicz MA; Menconi M; Rossen JW; Friedrich AW; Bathoorn E
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31694895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
    Richter SS; Karichu J; Otiso J; Van Heule H; Keller G; Cober E; Rojas LJ; Hujer AM; Hujer KM; Marshall S; Perez F; Rudin SD; Domitrovic TN; Kaye KS; Salata R; van Duin D; Bonomo RA
    Diagn Microbiol Infect Dis; 2018 May; 91(1):89-92. PubMed ID: 29456071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.